Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation


Por: Gabelli M, Pérez-Martínez A, Bueno Sánchez D, Lucchini G, Grenier LP, Couture F, Limerick E, Bernaud V, Trabazo-del Castillo M and Ngwube A

Publicada: 1 feb 2024 Ahead of Print: 1 dic 2023
Resumen:


Filiaciones:
Gabelli M:
 Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom

 Pediatric Hematology, Oncology and Stem Cell Transplantation, Università degli Studi di Padova, Padova, Italy

Pérez-Martínez A:
 Pediatric Hematology, Oncology and Stem Cell Transplantation, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Instituto de Investigación La Paz, Madrid, Spain

Bueno Sánchez D:
 Pediatric Hematology, Oncology and Stem Cell Transplantation, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Instituto de Investigación La Paz, Madrid, Spain

Grenier LP:
 Bone Marrow Transplantation, CHU de Québec-Université Laval, Hotel-Dieu de Québec, Québec, Canada

Couture F:
 Bone Marrow Transplantation, CHU de Québec-Université Laval, Hotel-Dieu de Québec, Québec, Canada

Limerick E:
 Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA

Bernaud V:
 Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA

Trabazo-del Castillo M:
 Pediatric Hematology, Oncology and Stem Cell Transplantation, Hospital Sant Joan de Déu, Barcelona, Spain

Ngwube A:
 Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA
ISSN: 02683369





BONE MARROW TRANSPLANTATION
Editorial
SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Letter
Volumen: 59 Número: 2
Páginas: 288-290
WOS Id: 001125040700001
ID de PubMed: 38097758

MÉTRICAS